NRAS mutation status is an independent prognostic factor in metastatic melanoma.
Jakob JA; Bassett RL Jr; Ng CS; Curry JL; Joseph RW; Alvarado GC; Rohlfs ML; Richard J; Gershenwald JE; Kim KB; Lazar AJ; Hwu P; Davies MA; Cancer, 2012, vol. 118, issue 16, p 4014, ISSN 10970142. ISBN 10970142.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef